Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program
Farah Hasan, Yulun Chiu, Rebecca M. Shaw, Junmei Wang, Cassian Yee
Farah Hasan, Yulun Chiu, Rebecca M. Shaw, Junmei Wang, Cassian Yee
View: Text | PDF
Research Article Immunology

Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program

  • Text
  • PDF
Abstract

Tissue-resident memory T cells (TRM) provide frontline defense against infectious diseases and contribute to antitumor immunity; however, aside from the necessity of TGF-β, knowledge regarding TRM-inductive cues remains incomplete, particularly for human cells. Oxygen tension is an environmental cue that distinguishes peripheral tissues from the circulation, and here, we demonstrate that differentiation of human CD8+ T cells in the presence of hypoxia and TGF-β1 led to the development of a TRM phenotype, characterized by a greater than 5-fold increase in CD69+CD103+ cells expressing human TRM hallmarks and enrichment for endogenous human TRM gene signatures, including increased adhesion molecule expression and decreased expression of genes involved in recirculation. Hypoxia and TGF-β1 synergized to produce a significantly larger population of TRM phenotype cells than either condition alone, and comparison of these cells from the individual and combination conditions revealed distinct phenotypic and transcriptional profiles, indicating a programming response to milieu rather than a mere expansion. Our findings identify a likely previously unreported cue for the TRM differentiation program and can enable facile generation of human TRM phenotype cells in vitro for basic studies and translational applications such as adoptive cellular therapy.

Authors

Farah Hasan, Yulun Chiu, Rebecca M. Shaw, Junmei Wang, Cassian Yee

×

Figure 2

Hypoxia + TGF-β1 induces transcriptional changes similar to those reported for endogenous TRM.

Options: View larger image (or click on image) Download as PowerPoint
Hypoxia + TGF-β1 induces transcriptional changes similar to those report...
CD69–CD103– (20% O2), CD69+CD103– (2% O2), and CD69+CD103+ (2% O2 + TGF-β1) CD8+ T cells were generated as described earlier and sorted before RNA isolation and transcriptome analysis via RNA sequencing (RNA-Seq) (n = 3). (A) Principal component analysis (PCA) of paired CD69–CD103–, CD69+CD103–, and CD69+CD103+ CD8+ T cells based on the global transcriptome. (B) Heatmap showing the top 250 differentially expressed genes (DEGs) for CD69–CD103– (gray), CD69+CD103– (blue), and CD69+CD103+ (red) cells generated in 20% O2, 2% O2, and 2% O2 + TGF-β1, respectively. Legend represents z score, orange color indicates upregulation and purple color indicates downregulation. Differential expression determined by |log2FC| ≥ 1 and FDR < 0.05. (C) Normalized expression levels of selected differentially expressed TRM-associated genes, showing min, median, and max. TNFRSF9, 4-1BB; RBPJ, recombination signal binding protein for immunoglobulin kappa J region; EGR2, early growth response 2.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts